uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
NCT07109518
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia (AML)
T Lymphoblastic Leukemia/Lymphoma
Interventions
BIOLOGICAL:
uCD7 CART
Sponsor
Institute of Hematology & Blood Diseases Hospital, China